Risankizumab – November 2022

• Brand names:
  • Skyrizi®
• Pharmaceutical Company:
  • AbbVie Pty Ltd
• Condition/Indication: Crohn Disease
• Meeting Date: November 2022
• Public Summary Document (PSD) July 2022 November 2022 PBAC Meetings - (PDF 967KB)
• Public Summary Document (PSD) July 2022 November 2022 PBAC Meetings - (Word 384KB)

Related Public Summary Documents

Risankizumab – July 2022